<a href="https://www.fiercebiotech.com/biotech/after-21b-novo-deal-vivtex-just-getting-started" hreflang="en">With $2B Novo deal in the books, Vivtex isn't 'limited to being just a drug delivery company': CEO</a>

For a professional interested in healthtech and biotech, the key insight is that leadership in biotech startups, as exemplified by Vivtex Therapeutics, requires a relentless drive and continuous innovation, even after securing significant funding deals. This mindset is crucial for maintaining competitive advantage and fostering long-term success in the rapidly evolving biotech sector.